{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:47:03Z","timestamp":1793044023013,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Key Laboratory of Cancer Biotherapy","award":["XZSYSKF2023037"],"award-info":[{"award-number":["XZSYSKF2023037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01825-8","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:29:27Z","timestamp":1738762167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cancer-associated fibroblast-derived COL17A1 promotes gemcitabine resistance and tumorigenesis in pancreatic cancer cells by interacting with ACTN4"],"prefix":"10.1007","volume":"16","author":[{"given":"Rongyu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"7","key":"1825_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18(7):493\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"1825_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1825_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3390\/jcm9041129","volume":"9","author":"JM Cloyd","year":"2020","unstructured":"Cloyd JM, Heh V, Pawlik TM, Ejaz A, Dillhoff M, Tsung A, et al. Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomized controlled trials. J Clin Med. 2020;9(4):1129.","journal-title":"J Clin Med"},{"issue":"3 Pt 2","key":"1825_CR4","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/j.lpm.2019.02.025","volume":"48","author":"C Springfeld","year":"2019","unstructured":"Springfeld C, J\u00e4ger D, B\u00fcchler MW, Strobel O, Hackert T, Palmer DH, et al. Chemotherapy for pancreatic cancer. Presse Med. 2019;48(3 Pt 2):e159\u201374.","journal-title":"Presse Med"},{"issue":"10242","key":"1825_CR5","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320.","journal-title":"Lancet"},{"key":"1825_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2021.08.029","volume":"521","author":"Z Gu","year":"2021","unstructured":"Gu Z, Du Y, Zhao X, Wang C. Tumor microenvironment and metabolic remodeling in gemcitabine-based chemoresistance of pancreatic cancer. Cancer Lett. 2021;521:98\u2013108.","journal-title":"Cancer Lett"},{"issue":"1","key":"1825_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"MZ Jin","year":"2020","unstructured":"Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5(1):166.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1825_CR8","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1038\/s41467-023-41518-w","volume":"14","author":"S Mayer","year":"2023","unstructured":"Mayer S, Milo T, Isaacson A, Halperin C, Miyara S, Stein Y, et al. The tumor microenvironment shows a hierarchy of cell-cell interactions dominated by fibroblasts. Nat Commun. 2023;14(1):5810.","journal-title":"Nat Commun"},{"issue":"9","key":"1825_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1825_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-019-1019-x","volume":"18","author":"JL Hu","year":"2019","unstructured":"Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, et al. Cafs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial\u2013mesenchymal transition in colorectal cancer. Mol Cancer. 2019;18(1):91.","journal-title":"Mol Cancer"},{"issue":"8","key":"1825_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2174\/1570180819666220718121827","volume":"20","author":"L Xian","year":"2023","unstructured":"Xian L, Xinlin W, Xiulan S. Crosstalk between exosomes and cafs during tumorigenesis, exosomederived biomarkers, and exosome-mediated drug delivery. Lett Drug Design Discov. 2023;20(8):977\u201391.","journal-title":"Lett Drug Design Discov"},{"issue":"27","key":"1825_CR12","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1073\/pnas.1600363113","volume":"113","author":"A Arina","year":"2016","unstructured":"Arina A, Idel C, Hyjek EM, Alegre ML, Wang Y, Bindokas VP, et al. Tumor-associated fibroblasts predominantly come from local and not circulating precursors. Proc Natl Acad Sci USA. 2016;113(27):7551\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1825_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1825_CR14","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","volume":"83","author":"J Zhuang","year":"2023","unstructured":"Zhuang J, Shen L, Li M, Sun J, Hao J, Li J, et al. Cancer-associated fibroblast-derived mir-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance. Cancer Res. 2023;83(10):1611\u201327.","journal-title":"Cancer Res"},{"key":"1825_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.897368","volume":"13","author":"Y Kittirat","year":"2022","unstructured":"Kittirat Y, Suksawat M, Thongchot S, Padthaisong S, Phetcharaburanin J, Wangwiwatsin A, et al. Interleukin-6-derived cancer-associated fibroblasts activate stat3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. Front Pharmacol. 2022;13: 897368.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1825_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12943-022-01501-3","volume":"21","author":"C Hu","year":"2022","unstructured":"Hu C, Xia R, Zhang X, Li T, Ye Y, Li G, et al. Circfarp1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the lif\/stat3 axis. Mol Cancer. 2022;21(1):24.","journal-title":"Mol Cancer"},{"issue":"11","key":"1825_CR17","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.3390\/cancers14112812","volume":"14","author":"KE Richards","year":"2022","unstructured":"Richards KE, Xiao W, Hill R, On Behalf Of The Usc Pancreas Research T. Cancer-associated fibroblasts confer gemcitabine resistance to pancreatic cancer cells through pten-targeting mirnas in exosomes. Cancers (Basel). 2022;14(11):2812.","journal-title":"Cancers (Basel)."},{"issue":"14","key":"1825_CR18","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1016\/j.cub.2021.04.078","volume":"31","author":"K Kozawa","year":"2021","unstructured":"Kozawa K, Sekai M, Ohba K, Ito S, Sako H, Maruyama T, et al. The cd44\/col17a1 pathway promotes the formation of multilayered, transformed epithelia. Curr Biol. 2021;31(14):3086-3097.e3087.","journal-title":"Curr Biol"},{"key":"1825_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.09.049","volume":"632","author":"J Yang","year":"2022","unstructured":"Yang J, Li Y, Sun Z, Fan Z, Shi M, Liu S, et al. Col17a1 facilitates tumor growth and predicts poor prognosis in pancreatic cancer. Biochem Biophys Res Commun. 2022;632:1\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1825_CR20","doi-asserted-by":"publisher","first-page":"8868245","DOI":"10.1155\/2020\/8868245","volume":"2020","author":"F Mao","year":"2020","unstructured":"Mao F, Li D, Xin Z, Du Y, Wang X, Xu P, et al. High expression of col17a1 predicts poor prognosis and promotes the tumor progression via nf-\u03bab pathway in pancreatic adenocarcinoma. J Oncol. 2020;2020:8868245.","journal-title":"J Oncol"},{"issue":"2","key":"1825_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100553","volume":"2","author":"T Yasuda","year":"2021","unstructured":"Yasuda T, Koiwa M, Yonemura A, Akiyama T, Baba H, Ishimoto T. Protocol to establish cancer-associated fibroblasts from surgically resected tissues and generate senescent fibroblasts. STAR Protoc. 2021;2(2): 100553.","journal-title":"STAR Protoc"},{"key":"1825_CR22","doi-asserted-by":"publisher","first-page":"153303382096211","DOI":"10.1177\/1533033820962117","volume":"19","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19:1533033820962117.","journal-title":"Technol Cancer Res Treat"},{"key":"1825_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.695645","volume":"11","author":"L Yang","year":"2021","unstructured":"Yang L, Bai Y, Li Q, Chen J, Liu F, Weng X, et al. Analysis of the curative effect of neoadjuvant therapy on pancreatic cancer. Front Oncol. 2021;11: 695645.","journal-title":"Front Oncol"},{"issue":"3","key":"1825_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152210","volume":"227","author":"V Sharma","year":"2022","unstructured":"Sharma V, Sachdeva N, Gupta V, Nada R, Jacob J, Sahni D, et al. Ccr4(+) monocytic myeloid-derived suppressor cells are associated with the increased epithelial-mesenchymal transition in pancreatic adenocarcinoma patients. Immunobiology. 2022;227(3): 152210.","journal-title":"Immunobiology"},{"issue":"6","key":"1825_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13107","volume":"94","author":"V Sharma","year":"2021","unstructured":"Sharma V, Sachdeva N, Gupta V, Nada R, Jacob J, Sahni D, et al. Il-6 is associated with expansion of myeloid-derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients. Scand J Immunol. 2021;94(6): e13107.","journal-title":"Scand J Immunol"},{"issue":"1","key":"1825_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41420-024-01958-9","volume":"10","author":"C Chen","year":"2024","unstructured":"Chen C, Liu J, Lin X, Xiang A, Ye Q, Guo J, et al. Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis. Cell Death Discov. 2024;10(1):189.","journal-title":"Cell Death Discov"},{"issue":"1","key":"1825_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of emt and therapy resistance. Mol Cancer. 2019;18(1):70.","journal-title":"Mol Cancer"},{"key":"1825_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216279","volume":"567","author":"W Luo","year":"2023","unstructured":"Luo W, Zhang T. Cancer-associated fibroblasts: a key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma. Cancer Lett. 2023;567: 216279.","journal-title":"Cancer Lett"},{"issue":"1","key":"1825_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113654","volume":"43","author":"JH Cao","year":"2024","unstructured":"Cao JH, Cao CH, Lin JL, Li SY, He LJ, Han K, et al. Neil1 drives the initiation of colorectal cancer through transcriptional regulation of col17a1. Cell Rep. 2024;43(1): 113654.","journal-title":"Cell Rep"},{"issue":"7","key":"1825_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255179","volume":"16","author":"M Lothong","year":"2021","unstructured":"Lothong M, Sakares W, Rojsitthisak P, Tanikawa C, Matsuda K, Yodsurang V. Collagen xvii inhibits breast cancer cell proliferation and growth through deactivation of the akt\/mtor signaling pathway. PLoS ONE. 2021;16(7): e0255179.","journal-title":"PLoS ONE"},{"key":"1825_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13148-016-0290-6","volume":"8","author":"PU Thangavelu","year":"2016","unstructured":"Thangavelu PU, Kren\u00e1cs T, Dray E, Duijf PH. In epithelial cancers, aberrant col17a1 promoter methylation predicts its misexpression and increased invasion. Clin Epigenetics. 2016;8:120.","journal-title":"Clin Epigenetics"},{"issue":"11","key":"1825_CR32","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1111\/cas.15952","volume":"114","author":"R Kashiwagi","year":"2023","unstructured":"Kashiwagi R, Funayama R, Aoki S, Matsui A, Klein S, Sato Y, et al. Collagen xvii regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. Cancer Sci. 2023;114(11):4286\u201398.","journal-title":"Cancer Sci"},{"issue":"11","key":"1825_CR33","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/cells8111427","volume":"8","author":"D Tentler","year":"2019","unstructured":"Tentler D, Lomert E, Novitskaya K, Barlev NA. Role of actn4 in tumorigenesis, metastasis, and emt. Cells. 2019;8(11):1427.","journal-title":"Cells"},{"key":"1825_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13578-015-0031-0","volume":"5","author":"K Honda","year":"2015","unstructured":"Honda K. The biological role of actinin-4 (actn4) in malignant phenotypes of cancer. Cell Biosci. 2015;5:41.","journal-title":"Cell Biosci"},{"issue":"11","key":"1825_CR35","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1002\/cam4.1837","volume":"7","author":"K Taniuchi","year":"2018","unstructured":"Taniuchi K, Furihata M, Naganuma S, Saibara T. Wave2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to actn4. Cancer Med. 2018;7(11):5733\u201351.","journal-title":"Cancer Med"},{"key":"1825_CR36","doi-asserted-by":"publisher","first-page":"1169833","DOI":"10.3389\/fonc.2023.1169833","volume":"13","author":"P Liu","year":"2023","unstructured":"Liu P, Liu S, Zhu C, Li Y, Li Y, Fei X, et al. The deubiquitinating enzyme mindy2 promotes pancreatic cancer proliferation and metastasis by stabilizing actn4 expression and activating the pi3k\/akt\/mtor signaling pathway. Front Oncol. 2023;13:1169833.","journal-title":"Front Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01825-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01825-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01825-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T01:17:47Z","timestamp":1738804667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01825-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1825"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01825-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This experiments was allowed to perform by the ethical committee of the First People\u2019s Hospital of Jiashan County. The animal experiments were authorized by the Animal Ethical Committee of First People\u2019s Hospital of Jiashan County.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not\u00a0applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}